Bittium (BITTI) Q2 2025 earnings summary

Executive summary

• Net sales for H1 2025 grew 11.3% year-on-year to EUR 42.2 million, with Q2 net sales up 15.6% to EUR 22.9 million, mainly driven by Defense & Security segment growth.

• Order book/backlog increased 27.5% year-on-year to EUR 43.1 million, reflecting strong demand in Defense & Security.

• Operating result for H1 2025 was EUR 1.5 million (3.6% of net sales), impacted by growth investments and EUR 0.9 million non-recurring costs in the Medical segment.

• Cash flow from operating activities improved to EUR 9.2 million, and the company remains net debt-free with a strong equity ratio.

• Dividend of EUR 3.5 million (EUR 0.10 per share) paid in H1 2025; new CEO and management changes implemented.

Financial highlights

• H1 2025 net sales: EUR 42.2 million (+11.3% y-on-y); Q2 net sales: EUR 22.9 million (+15.6% y-on-y).

• H1 2025 operating result: EUR 1.5 million (3.6% margin); Q2 operating result: EUR 1.1 million (4.9% margin).

• EBITDA for H1 2025 was EUR 4.8 million (11.4% of net sales), down from EUR 7.4 million (19.5%) year-over-year.

• Equity ratio at 70.7%; net gearing at -0.9%; cash and liquid assets at EUR 21.7 million.

• Dividend payment of EUR 3.5 million included in financing activities.

Outlook and guidance

• Full-year 2025 net sales expected between EUR 95 million and EUR 105 million (EUR 85.2 million in 2024).

• Operating result forecasted at EUR 10 million–EUR 13 million (EUR 8.6 million in 2024).

• Growth strategy focuses on international sales, product development, and operational efficiency.

• Strong order book and solid plan for the second half support confidence in meeting guidance.